Alpha Tau Medical Ltd. announced that a patient with advanced inoperable pancreatic cancer has been treated in a clinical trial at Hadassah Medical Center in Jerusalem, Israel. The trial is designed for a broad range of solid tumor patients who do not qualify for participation in other existing trials or who do not have other treatment options according to the treating physician.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 USD | -1.60% | -1.20% | -18.27% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.27% | 174M | |
+162.86% | 6.83B | |
+0.52% | 1.01B | |
+2.29% | 982M | |
+41.91% | 872M | |
+22.57% | 797M | |
+1.82% | 664M | |
-1.80% | 617M | |
-.--% | 600M | |
+29.07% | 592M |
- Stock Market
- Equities
- DRTS Stock
- News Alpha Tau Medical Ltd.
- Alpha Tau Medical Ltd. Treats First Patient with Advanced Inoperable Pancreatic Cancer At Israel's Hadassah Medical Center